These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12616334)

  • 41. Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking.
    Lindsey KP; Bracken BK; Maclean RR; Ryan ET; Lukas SE; Frederick BD
    Pharmacol Biochem Behav; 2013 Feb; 103(4):710-6. PubMed ID: 23219727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler.
    West R; Hajek P; Foulds J; Nilsson F; May S; Meadows A
    Psychopharmacology (Berl); 2000 Apr; 149(3):198-202. PubMed ID: 10823399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.
    Blank MD; Sams C; Weaver MF; Eissenberg T
    Nicotine Tob Res; 2008 Mar; 10(3):417-21. PubMed ID: 18324559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silver acetate interactions with nicotine and non-nicotine smoke components.
    Rose JE; Behm FM; Murugesan T; McClernon FJ
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):462-9. PubMed ID: 21186921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
    Kotlyar M; Mendoza-Baumgart MI; Li ZZ; Pentel PR; Barnett BC; Feuer RM; Smith EA; Hatsukami DK
    Tob Control; 2007 Apr; 16(2):138-42. PubMed ID: 17400953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men.
    Mendelson JH; Goletiani N; Sholar MB; Siegel AJ; Mello NK
    Neuropsychopharmacology; 2008 Mar; 33(4):749-60. PubMed ID: 17507912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The acute effect of Swedish-style snus on cigarette craving and self-administration in male and female smokers.
    Barrett SP; Campbell ML; Temporale K; Good KB
    Hum Psychopharmacol; 2011 Jan; 26(1):58-62. PubMed ID: 21305611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.
    Dar R; Barrett SP
    J Psychopharmacol; 2014 Nov; 28(11):1071-9. PubMed ID: 25253274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation.
    Severson HH; Danaher BG; Ebbert JO; van Meter N; Lichtenstein E; Widdop C; Crowley R; Akers L; Seeley JR
    Nicotine Tob Res; 2015 Mar; 17(3):309-15. PubMed ID: 25168034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotine Lozenges in the Relief of Behaviorally Provoked Craving.
    Nides M; Shanga GM; Bishop A; Becker WD
    Am J Health Behav; 2018 May; 42(3):69-80. PubMed ID: 29663982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute effects of nicotine on alcohol cue-reactivity in nondependent and dependent smokers.
    McGrath DS; Peloquin MP; Ferdinand JC; Barrett SP
    Exp Clin Psychopharmacol; 2015 Feb; 23(1):29-36. PubMed ID: 25643027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of craving and withdrawal among four combination nicotine treatments.
    Schneider NG; Cortner C; Gould JL; Koury MA; Olmstead RE
    Hum Psychopharmacol; 2008 Aug; 23(6):513-7. PubMed ID: 18438964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E; Piekoszewski W
    Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progressive reduction using nicotine gum as a prelude to quitting.
    Jiménez-Ruiz CA; Ulibarri MM; Besada NA; Guerrero AC; Garcia AG; Cuadrado AR
    Nicotine Tob Res; 2009 Jul; 11(7):847-50. PubMed ID: 19443787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative testing of 5 nicotine systems: initial use and preferences.
    Schneider NG; Olmstead RE; Nides M; Mody FV; Otte-Colquette P; Doan K; Patel S
    Am J Health Behav; 2004; 28(1):72-86. PubMed ID: 14977161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preferences among five nicotine treatments based on information versus sampling.
    Schneider NG; Cortner C; Justice M; Gould JL; Amor C; Hartman N; Kleinman L; Olmstead RE
    Nicotine Tob Res; 2008 Jan; 10(1):179-86. PubMed ID: 18188758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of high-dose nicotine patch on the characteristics of lapse episodes.
    Ferguson SG; Shiffman S
    Health Psychol; 2010 Jul; 29(4):358-66. PubMed ID: 20658822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.